Intracranial Pressure Monitoring Devices Market size is anticipated to register expansive expansion between 2023 to 2032 due to the increasing prevalence of neurological disorders and the rise in cases of traumatic accidents. ICP monitoring devices are frequently used to evaluate pressure in the cranium and brain caused by neurological diseases or trauma.
Rising rates of meningitis, brain infections, and aneurysms in the global population will raise the demand for ICP monitoring devices. Meningitis remains a global public health burden in some economies, according to WHO estimates. The agency estimates that one in every ten patients dies due to bacterial meningitis, and one in every five suffers from significant consequences.
Growing geriatric population and strong revenue in foreign investment will further drive the ICP monitoring equipment market progress. Governments in several developing economies continue to invest heavily in improving patient-centered care, efficiency, and safety.
However, the lack of trained professionals for the operation of the devices and the high procedural costs associated with the deployment of ICP pressure devices will pose challenges in expanding the progression of the intracranial pressure monitoring devices market during the analysis period.
Based on technology, the market for non-invasive ICP monitoring equipment, such as CT/MRI scanners and devices that measure the width of the optic nerve sheath, will experience considerable growth by 2032. MRI/CT scans could record significant gains across as morphological features of CT scans of the brain can be potentially used to estimate ICP through an image-processing algorithm. Such predictions can be used to predict outcomes and avert the placement of invasive intracranial monitors in patients with severe traumatic brain injury.
In terms of application, the Intracranial Pressure Monitoring Devices Market size is expected to grow from the cerebral edema and central nervous system infection segment. PCI monitoring is considered the most accessible monitoring method for brain-injured patients, primarily due to the lack of consistent and reliable methods for measuring cerebral edema. Additionally, non-invasive procedures such as CT scans and MRIs have been chosen as methods of visualizing cerebral edema.
Based on the regional outlook, North America ICP surveillance equipment industry, led by the United States and Canada, is expected to hold a significant share in the coming years.
Intracranial Pressure (ICP) Monitoring Devices Marketis inclusive of companies such as Codman & Shurtleff, Johnson & Johnson, Medtronic plc, DePuy Synthes Companies, Integra LifeScience Corporation, Vittamed, HeadSense Medical, Vivonics Inc, Orsan Medical Technologies, and Spiegelberg. Strategies like new product launches, mergers, and partnerships will aid these firms to expand their business footprint in the competitive market